Ultivue by Vizgen is at the forefront of spatial biology and multi-omics innovation. Through its high-fidelity InSituPlex® proteomic assays and AI-driven STARVUE™ spatial image analysis technology, Ultivue by Vizgen delivers unmatched tools that enable researchers to uncover deep insights into human biology and achieve breakthroughs in understanding mechanisms of complex diseases with high precision and accuracy, thereby facilitating advanced therapeutic development, including next-generation immunotherapies. Ultivue by Vizgen is headquartered in Cambridge, Massachusetts